Skip to main content

Table 1 Baseline characteristics of 477 HIV-infected children

From: Impact of antiretroviral treatment on height evolution of HIV infected children

N (%) or median [IQR]

All

Height-for-age z-score at ART initiation

p-value

<−3 SD

−3 to < − 2 SD

− 2 to < − 1 SD

≥ − 1 SD

All

477

116 (24%)

119 (25%)

119 (25%)

123 (26%)

 

Male

206 (43%)

56 (48%)

55 (46%)

43 (36%)

52 (42%)

0.25a

Age (years)

6.2 [1.8–9.6]

7.7 [5.1–10.6]

7.4 [3.9–9.9]

5.6 [1.5–9.5]

2.0 [0.8–6.5]

< 0.001b

ART regimen

     

< 0.001a

 Dual NRTI-based regimen

41 (9%)

1 (1%)

5 (4%)

15 (13%)

20 (16%)

 

 PI-based regimen

57 (12%)

5 (4%)

8 (7%)

16 (13%)

28 (23%)

 

 NNRTI-based regimen

379 (79%)

110 (95%)

106 (89%)

88 (74%)

75 (61%)

 

CD4 percentage

9 [2–17]

5 [1–11]

4 [1–13]

11 [4–18]

16 [10–23]

< 0.001b

HIV-RNA load (log10copies/mL)

5.17 [4.69–5.67]

5.16 [4.74–5.59]

5.20 [4.66–5.62]

5.13 [4.82–5.55]

5.22 [4.41–5.89]

0.98b

CDC HIV classification stage

     

< 0.001a

 N

87 (18%)

12 (10%)

15 (13%)

20 (17%)

40 (33%)

 

 A

136 (28%)

25 (22%)

32 (27%)

41 (34%)

38 (31%)

 

 B

132 (28%)

34 (29%)

32 (27%)

38 (32%)

28 (23%)

 

 C

17 (26%)

45 (39%)

40 (33%)

20 (17%)

17 (23%)

 

Weight-for-age z-score

     

< 0.001a

  < −3 SD

18 (4%)

9 (8%)

7 (6%)

1 (1%)

1 (1%)

 

  − 3 to <−2 SD

59 (12%)

33 (28%)

12 (10%)

12 (10%)

2 (2%)

 

  − 2 to <−1 SD

196 (41%)

66 (57%)

68 (57%)

46 (39%)

16 (13%)

 

  ≥ 1 SD

204 (43%)

8 (7%)

32 (27%)

60 (50%)

104 (84%)

 

Weight-for-height z-score

     

0.72a

  < −3 SD

5 (1%)

2 (2%)

2 (2%)

1 (1%)

–

 

 – 3 to <−2 SD

27 (6%)

7 (6%)

9 (7%)

6 (5%)

5 (4%)

 

 – 2 to <−1 SD

95 (20%)

27 (23%)

25 (21%)

22 (18%)

21 (17%)

 

  ≥ −1 SD

350 (73%)

80 (69%)

83 (70%)

90 (76%)

97 (79%)

 
  1. CDC Centers for Disease Control and Prevention, IQR interquartile range, N number of children in category
  2. a Chi-square test
  3. b Kruskal-Wallis test